BFRI

MKT CAP:$11M

Biofrontera Inc

Market Cap

$11M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$0.94+$0.21 (+28.97%)

Jun 5, 2026

52W High $1.1652W Low $0.57

Company Details

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and Rhod...

CEO

—

IPO Date

Oct 29, 2021

Website

www.biofrontera-us.com

Key Metrics TTM

Revenue

$43M

+13.7% YoY

Net Income

-$11M

EPS (Diluted)

Free Cash Flow

-$9M

Revenue / Share

$3.70

Gross Margin

82.8%

Operating Margin

-20.6%

Net Margin

-25.7%

FCF Margin

-21.6%

P/S

0.3x

P/E

Earnings Reports

Q2 2026

Aug 12, 2026

PENDING

Q1 2026

May 14, 2026

$10M+17.4%

FY 2025

Mar 19, 2026

$42M+11.8%

Q4 2025

Mar 19, 2026

$17M+36.2%

Q3 2025

Nov 12, 2025

$7M-22.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee